Neurocrine Biosciences, Inc.
Cash Flow Statement
| Line Item | FY2009 |
|---|---|
| Operating Activities | |
| Net Income | $-51.0M |
| Depreciation & Amortization | $3.2M |
| Depreciation | — |
| Amortization | — |
| Stock-Based Compensation | $5.5M |
| Net Cash from Operating Activities | $-53.1M |
| Investing Activities | |
| Capital Expenditures | $35.0K |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $12.1M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $9.9M |
| Net Change in Cash | $-31.1M |
| Free Cash Flow | $-53.1M |